652 related articles for article (PubMed ID: 18344963)
1. Pathological changes in the vitreoretinal junction 1: epiretinal membrane formation.
Snead DR; James S; Snead MP
Eye (Lond); 2008 Oct; 22(10):1310-7. PubMed ID: 18344963
[TBL] [Abstract][Full Text] [Related]
2. Hyperconvolution of the inner limiting membrane in vitreomaculopathies.
Snead DR; Cullen N; James S; Poulson AV; Morris AH; Lukaris A; Scott JD; Richards AJ; Snead MP
Graefes Arch Clin Exp Ophthalmol; 2004 Oct; 242(10):853-62. PubMed ID: 15480733
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis and cell proliferation in proliferative retinal disorders: PCNA, Ki-67, caspase-3, and PARP expression.
Zhang X; Barile G; Chang S; Hays A; Pachydaki S; Schiff W; Sparrow J
Curr Eye Res; 2005 May; 30(5):395-403. PubMed ID: 16020270
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of RAGE and its ligands in proliferative retinal disease.
Pachydaki SI; Tari SR; Lee SE; Ma W; Tseng JJ; Sosunov AA; Cataldergirmen G; Scarmeas N; Caspersen C; Chang S; Schiff WM; Schmidt AM; Barile GR
Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
[TBL] [Abstract][Full Text] [Related]
5. Epithelial-mesenchymal transition in proliferative vitreoretinopathy: intermediate filament protein expression in retinal pigment epithelial cells.
Casaroli-Marano RP; Pagan R; Vilaró S
Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2062-72. PubMed ID: 10440262
[TBL] [Abstract][Full Text] [Related]
6. Epiretinal pathology of diffuse diabetic macular edema associated with vitreomacular traction.
Gandorfer A; Rohleder M; Grosselfinger S; Haritoglou C; Ulbig M; Kampik A
Am J Ophthalmol; 2005 Apr; 139(4):638-52. PubMed ID: 15808159
[TBL] [Abstract][Full Text] [Related]
7. Ultrastructure of the vitreomacular interface in full-thickness idiopathic macular holes: a consecutive analysis of 100 cases.
Schumann RG; Schaumberger MM; Rohleder M; Haritoglou C; Kampik A; Gandorfer A
Am J Ophthalmol; 2006 Jun; 141(6):1112-1119. PubMed ID: 16765681
[TBL] [Abstract][Full Text] [Related]
8. Immunoreactive ET-1 in the vitreous humor and epiretinal membranes of patients with proliferative vitreoretinopathy.
Roldán-Pallarés M; Rollín R; Mediero A; Martínez-Montero JC; Fernández-Cruz A; Bravo-Llata C; Fernández-Durango R
Mol Vis; 2005 Jul; 11():461-71. PubMed ID: 16030497
[TBL] [Abstract][Full Text] [Related]
9. Residual cellular proliferation on the internal limiting membrane in macular pucker surgery.
Gandorfer A; Haritoglou C; Scheler R; Schumann R; Zhao F; Kampik A
Retina; 2012 Mar; 32(3):477-85. PubMed ID: 22068175
[TBL] [Abstract][Full Text] [Related]
10. Macular hole retinal detachment in highly myopic eyes: ultrastructure of surgically removed epiretinal membrane and clinicopathologic correlation.
Ishida S; Yamazaki K; Shinoda K; Kawashima S; Oguchi Y
Retina; 2000; 20(2):176-83. PubMed ID: 10783951
[TBL] [Abstract][Full Text] [Related]
11. [Immunohistochemical study on vitrectomy specimens of proliferative retinal diseases].
Cao J; Wu L; Zhang H
Zhonghua Yan Ke Za Zhi; 1997 Jul; 33(4):264-7. PubMed ID: 10451957
[TBL] [Abstract][Full Text] [Related]
12. Localisation of opticin in human proliferative retinal disease.
Pattwell DM; Sheridan CM; Le Goff M; Bishop PN; Hiscott P
Exp Eye Res; 2010 Mar; 90(3):461-4. PubMed ID: 20036236
[TBL] [Abstract][Full Text] [Related]
13. [Pathomorphology of membranes appearing in proliferative vitreoretinopathies].
Laudańska-Olszewska I; Omulecki W; Dziegielewski K; Pikulski Z; Omulecka A
Klin Oczna; 2006; 108(1-3):28-31. PubMed ID: 16883935
[TBL] [Abstract][Full Text] [Related]
14. Cell proliferation in human epiretinal membranes: characterization of cell types and correlation with disease condition and duration.
Oberstein SY; Byun J; Herrera D; Chapin EA; Fisher SK; Lewis GP
Mol Vis; 2011; 17():1794-805. PubMed ID: 21750605
[TBL] [Abstract][Full Text] [Related]
15. Epiretinal cell proliferation in macular pucker and vitreomacular traction syndrome: analysis of flat-mounted internal limiting membrane specimens.
Zhao F; Gandorfer A; Haritoglou C; Scheler R; Schaumberger MM; Kampik A; Schumann RG
Retina; 2013 Jan; 33(1):77-88. PubMed ID: 22914684
[TBL] [Abstract][Full Text] [Related]
16. Effect of Robo1 on retinal pigment epithelial cells and experimental proliferative vitreoretinopathy.
Huang L; Xu Y; Yu W; Li Y; Chu L; Dong J; Li X
Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3193-204. PubMed ID: 20071679
[TBL] [Abstract][Full Text] [Related]
17. TGF-beta1, TGF-beta receptor II and ED-A fibronectin expression in myofibroblast of vitreoretinopathy.
Bochaton-Piallat ML; Kapetanios AD; Donati G; Redard M; Gabbiani G; Pournaras CJ
Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2336-42. PubMed ID: 10892881
[TBL] [Abstract][Full Text] [Related]
18. Immunocytochemical and ultrastructural evidence of glial cells and hyalocytes in internal limiting membrane specimens of idiopathic macular holes.
Schumann RG; Eibl KH; Zhao F; Scheerbaum M; Scheler R; Schaumberger MM; Wehnes H; Walch AK; Haritoglou C; Kampik A; Gandorfer A
Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):7822-34. PubMed ID: 21900375
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis in proliferative vitreoretinal disorders: possible involvement of TGF-beta-induced RPE cell apoptosis.
Esser P; Heimann K; Bartz-schmidt KU; Fontana A; Schraermeyer U; Thumann G; Weller M
Exp Eye Res; 1997 Sep; 65(3):365-78. PubMed ID: 9299173
[TBL] [Abstract][Full Text] [Related]
20. Pathology of the macular hole rim in flat-mounted internal limiting membrane specimens.
Gandorfer A; Scheler R; Haritoglou C; Schumann R; Nentwich M; Kampik A
Retina; 2009 Sep; 29(8):1097-105. PubMed ID: 19734763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
